Profile data is unavailable for this security.
About the company
Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through three business segments: BD Medical, BD Life Sciences and BD Interventional. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including medication delivery solutions, medication management solutions, diabetes care and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The BD Interventional segment provides vascular, urology, oncology and surgical specialty products.
- Revenue in USD (TTM)20.03bn
- Net income in USD1.83bn
- LocationBecton Dickinson and CoOne Becton DriveFRANKLIN LAKES 07417-1880United StatesUSA
- Phone+1 (201) 847-6800
Mergers & acquisitions
|Acquired company||Deal status||Date||Date /|
|BDX:NYQ since |
|Parata Systems LLC||Announced||06 Jun 2022||06 Jun 2022Announced||-0.21%||1.53bn|
|Cytognos SL||Deal completed||31 Jan 2022||31 Jan 2022Deal completed||-1.54%||--|
|Scanwell Health Inc||Deal completed||21 Dec 2021||21 Dec 2021Deal completed||-0.24%||--|
|Tissuemed Ltd||Deal completed||09 Dec 2021||09 Dec 2021Deal completed||2.17%||--|
|Venclose Inc||Deal completed||02 Dec 2021||02 Dec 2021Deal completed||4.19%||--|